Foresee Pharmaceuticals Co (ROCO:6576) Valuation Rank


ROCO:6576 Foresee Pharmaceuticals Co Ltd ROCO:6576
58 GF Score
Price NT$83.10
GF Value NT$96.69
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Foresee Pharmaceuticals Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Foresee Pharmaceuticals Co Valuation Rank Related Terms

ROCO:6576
58GF Score
Foresee Pharmaceuticals Co Ltd ROCO:6576
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?

Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$83.10 is trading 14.1% below its estimated GF Value™ of NT$96.69. GuruFocus considers Foresee Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for ROCO:6576:

  • Valuation Rank:
  • GF Value™: NT$96.69 vs. price of NT$83.10 (14.1% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Foresee Pharmaceuticals Co Business Description

Address No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
58GF Score

Get the complete analysis for ROCO:6576

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.10
Price
NT$96.69
GF Value